CEO Andrea Pfeifer formed the basis of an extensive article in S&P Global Market Intelligence on the prospect of new treatments in Alzheimer’s disease

May 27, 2019

The S&P article is the first in a series focusing on Alzheimer's and offers the opportunity to articulate further AC Immune’s Roadmap to Successful Therapies for Neurodegenerative Diseases.

Full article in English